Case report: anti-GAD65 antibody-associated epilepsy as the primary manifestation of chronic graft-versus-host disease

Read full text Summarise with VIRAT
Authors: Suge Yang, Pengchen Gu, J M Tian, Xiaowen Tang, Qun Xue
Cited by: 0
References: 27

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Central nervous system involvement in chronic graft-versus-host disease (CNS-cGVHD) is rare. This case report describes a young man who developed anti-glutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy after undergoing matched sibling donor hematopoietic stem cell transplantation. The therapeutic approach included intensive immunotherapy with methylprednisolone, immunoadsorption, Rituximab, and low-dose Daratumumab, in combination with four antiepileptic drugs and mycophenolate mofetil. This regimen led to a marked reduction in anti-GAD65 titers and an improvement in the NHS3 seizure severity score, decreasing from 8 to 3. Additionally, a review of the literature on post-transplant autoimmune encephalitis is also provided.

Fields of Study & Subjects

Autoimmune Neurological Disorders and Treatments Hematopoietic Stem Cell Transplantation Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
Annals of Hematology
Volume
105
Issue
4
Pages
214
Publication date
30 March 2026
Language
EN